Use the keywords feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
JOURNAL ARTICLE
Pearl L H Mok, Matthew J Carr, Bruce Guthrie, Daniel R Morales, Aziz Sheikh, Rachel A Elliott, Elizabeth M Camacho, Tjeerd van Staa, Anthony J Avery, Darren M Ashcroft
OBJECTIVE: To investigate risks of multiple adverse outcomes associated with use of antipsychotics in people with dementia. DESIGN: Population based matched cohort study. SETTING: Linked primary care, hospital and mortality data from Clinical Practice Research Datalink (CPRD), England. POPULATION: Adults (≥50 years) with a diagnosis of dementia between 1 January 1998 and 31 May 2018 (n=173 910, 63.0% women)...
April 17, 2024: BMJ: British Medical Journal
#2
EDITORIAL
Martin H Voss, Robert J Motzer
New England Journal of Medicine, Volume 390, Issue 15, Page 1432-1433, April 2024.
April 18, 2024: New England Journal of Medicine
#3
JOURNAL ARTICLE
Jenny J Linnoila, Otto Rapalino, Melissa A Walker, Maria Martinez-Lage
New England Journal of Medicine, Volume 390, Issue 15, Page 1421-1430, April 2024.
April 18, 2024: New England Journal of Medicine
#4
JOURNAL ARTICLE
Bailang Chen, Minxin Wei
New England Journal of Medicine, Volume 390, Issue 15, Page 1420-1420, April 2024.
April 18, 2024: New England Journal of Medicine
#5
REVIEW
David Cobrinik
New England Journal of Medicine, Volume 390, Issue 15, Page 1408-1419, April 2024.
April 18, 2024: New England Journal of Medicine
#6
JOURNAL ARTICLE
Toni K Choueiri, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Tom Ferguson, Stefan N Symeonides, Jaroslav Hajek, Yen-Hwa Chang, Jae-Lyun Lee, Naveed Sarwar, Naomi B Haas, Howard Gurney, Piotr Sawrycki, Mauricio Mahave, Marine Gross-Goupil, Tian Zhang, John M Burke, Gurjyot Doshi, Bohuslav Melichar, Evgeniy Kopyltsov, Ajjai Alva, Stephane Oudard, Delphine Topart, Hans Hammers, Hiroshi Kitamura, David F McDermott, Adriano Silva, Eric Winquist, Jerry Cornell, Aymen Elfiky, Joseph E Burgents, Rodolfo F Perini, Thomas Powles
BACKGROUND: Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results regarding overall survival from the third prespecified interim analysis of the trial would also favor pembrolizumab was uncertain. METHODS: In this phase 3, double-blind, placebo-controlled trial, we randomly assigned (in a 1:1 ratio) participants with clear-cell renal-cell carcinoma who had an increased risk of recurrence after surgery to receive pembrolizumab (at a dose of 200 mg) or placebo every 3 weeks for up to 17 cycles (approximately 1 year) or until recurrence, the occurrence of unacceptable toxic effects, or withdrawal of consent...
April 18, 2024: New England Journal of Medicine
#7
JOURNAL ARTICLE
(no author information available yet)
New England Journal of Medicine, Volume 390, Issue 15, April 2024.
April 18, 2024: New England Journal of Medicine
#8
JOURNAL ARTICLE
Ezekiel J Emanuel, Johan L Dellgren, Matthew S McCoy, Govind Persad
No abstract text is available yet for this article.
April 17, 2024: New England Journal of Medicine
#9
JOURNAL ARTICLE
Farrin A Manian
New England Journal of Medicine, Volume 390, Issue 15, Page 1356-1357, April 2024.
April 13, 2024: New England Journal of Medicine
#10
JOURNAL ARTICLE
Stephanie M Fullerton, Kyle B Brothers
New England Journal of Medicine, Volume 390, Issue 15, Page 1349-1351, April 2024.
April 13, 2024: New England Journal of Medicine
#11
JOURNAL ARTICLE
Carlos Carazo Casas, Marimar Medina Gonzalez
New England Journal of Medicine, Volume 390, Issue 15, April 2024.
April 13, 2024: New England Journal of Medicine
#12
JOURNAL ARTICLE
Jeni Miller, Courtney Howard, Lujain Alqodmani
New England Journal of Medicine, Volume 390, Issue 15, Page 1354-1356, April 2024.
April 13, 2024: New England Journal of Medicine
#13
JOURNAL ARTICLE
David Hemenway
New England Journal of Medicine, Volume 390, Issue 15, Page 1352-1353, April 2024.
April 13, 2024: New England Journal of Medicine
#14
JOURNAL ARTICLE
Lu Zhang, Lifeng Shi, Ruijie Zhang, Xinao Lin, Yunlei Bao, Feng Jiang, Chuyan Wu, Jimei Wang
BACKGROUND: Kawasaki disease is a systemic vascular disease with an unclear pathophysiology that primarily affects children under the age of five. Research on immune control in Kawasaki disease has been gaining attention. This study aims to apply a bibliometric analysis to examine the present and future directions of immune control in Kawasaki disease. METHODS: By utilizing the themes "Kawasaki disease," "Kawasaki syndrome," and "immune control," the Web of Science Core Collection database was searched for publications on immune control in Kawasaki disease...
April 11, 2024: Cardiology in the Young
#15
JOURNAL ARTICLE
Nishant Uppal, Zirui Song
No abstract text is available yet for this article.
April 10, 2024: New England Journal of Medicine
#16
JOURNAL ARTICLE
Charlene A Wong, Debra Houry, Mandy K Cohen
No abstract text is available yet for this article.
April 10, 2024: New England Journal of Medicine
#17
JOURNAL ARTICLE
Eric Reinhart
New England Journal of Medicine, Volume 390, Issue 14, Page 1333-1338, April 2024.
April 11, 2024: New England Journal of Medicine
#18
EDITORIAL
Misty R Jenkins, Katharine J Drummond
New England Journal of Medicine, Volume 390, Issue 14, Page 1329-1332, April 2024.
April 11, 2024: New England Journal of Medicine
#19
EDITORIAL
A David Mendelow
New England Journal of Medicine, Volume 390, Issue 14, Page 1328-1329, April 2024.
April 11, 2024: New England Journal of Medicine
#20
EDITORIAL
Antonio Passaro, Solange Peters
New England Journal of Medicine, Volume 390, Issue 14, Page 1325-1327, April 2024.
April 11, 2024: New England Journal of Medicine
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
